🔗 Share this article

Chancellor Rachel Reeves has announced she is planning "specific action to address cost of living pressures" in the forthcoming financial statement.

Speaking to the BBC, she emphasized that curbing price rises is a shared responsibility of both the administration and the Bank of England.

The United Kingdom's price growth is expected to be the most elevated among the Group of Seven industrialized countries this year and the following year.

Possible Energy Bill Interventions

Sources suggest the government could intervene to reduce energy bills, for instance by slashing the present 5% rate of value-added tax charged on energy supplies.

Another approach is to lower some of the regulatory levies presently included in bills.

Budgetary Constraints and Expert Expectations

The government will receive the next assessment from the independent fiscal watchdog, the OBR, on the start of the week, which will show how much room there is for such actions.

The consensus from most analysts is that Reeves will have to declare higher taxes or expenditure reductions in order to fulfill her self-imposed fiscal targets.

Previously on Thursday, calculations indicated there was a twenty-two billion pound gap for the Treasury chief to fill, which is at the more modest range of forecasts.

"It is a collective task between the Bank of England and the government to continue tackling some of the sources of inflation," the Chancellor told reporters in Washington, at the yearly gatherings of the IMF and World Bank.

Tax Pledges and International Issues

While a great deal of the attention has been on probable tax rises, the Treasury chief said the most recent figures from the OBR had not altered her pledge to campaign commitments not to increase tax levels on income tax, sales tax or National Insurance.

She blamed an "unpredictable global environment" with growing international and commercial tensions for the fiscal revenue measures, probably to be directed on those "most able to pay."

Global Trade Disputes

Referring to concerns about the United Kingdom's commercial links with the Asian nation she said: "The UK's national security invariably take priority."

Recent declaration by Chinese authorities to increase export controls on rare earths and other materials that are essential for high-technology production led US President Donald Trump to threaten an further 100% import tax on imports from China, raising the prospect of an all-out commercial conflict between the two global powers.

The US Treasury Secretary called China's decision "economic coercion" and "a global supply chain control attempt."

Questioned on considering the US offer to join its battle with the Asian nation, Reeves said she was "deeply worried" by Chinese actions and urged the Beijing authorities "to avoid restrictions and restrict access."

She said the decision was "damaging for the international commerce and creates additional obstacles."

"It is my opinion there are fields where we should confront Chinese policies, but there are also valuable opportunities to trade with China's economy, including banking sector and other areas of the economic system. We've got to maintain that balance appropriate."

The Treasury chief also affirmed she was cooperating with G7 counterparts "regarding our own essential resources plan, so that we are more independent."

Health Service Drug Pricing and Investment

Reeves also admitted that the cost the National Health Service spends on drugs could increase as a result of ongoing negotiations with the Trump administration and its drugs companies, in return for reduced taxes and investment.

Some of the world's largest pharmaceutical manufacturers have said in recent statements that they are either halting or canceling projects in the UK, with some blaming the low prices they are getting.

Recently, the government science advisor said the price the health service pays for medicines would have to go up to prevent companies and pharmaceutical investment departing from the UK.

The Chancellor stated to the BBC: "It has been observed due to the cost structure, that drug testing, new drugs have not been provided in the UK in the way that they are in other EU nations."

"Our aim is to ensure that people getting care from the National Health Service are able to receive the finest essential treatments in the globe. And so we are reviewing these issues, and... seeking to attract additional funding into the UK."